Radiopharm Theranostics Limited (RADX) Net margin 2023–2025
Radiopharm Theranostics Limited (RADX) net profit margin by fiscal year — reported net income divided by reported revenue.
-1055.3%FY2025 · since FY2023: -11838.6% → -1055.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1055.3% | +14969.0 pp |
| FY2024 | -16024.3% | -4185.7 pp |
| FY2023 | -11838.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice